From the Department of Internal Medicine, University of Texas Medical
Branch, Galveston, Texas.
Correspondence to Donna H. Wang, MD, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555-1065. E-mail dwang{at}utmb.edu
AbstractIt has been shown that
aldosterone potentiates the action of
angiotensin II (Ang II) in cultured rat vascular smooth
muscle cells solely by increasing the number of Ang II receptors. The
mechanisms responsible for aldosteroneAng II interactions
in the adrenal gland are unknown. The present study was designed to
investigate the effect of aldosterone on expression of Ang
II receptor subtypes (AT1 and AT2) in the
adrenal gland. Seven-week-old male Wistar rats were treated for 2 weeks
with either aldosterone (0.05 µg/h, n=14) or vehicle
(n=14) by use of implanted osmotic minipumps. Systolic blood
pressure was not altered by aldosterone treatment. Plasma
aldosterone levels were higher in
aldosterone-treated rats (181±53 pg/mL) compared with
vehicle-treated rats (33±21 pg/mL, P<0.05). Northern
blot analysis and radioligand binding assay showed
that adrenal AT1 mRNA levels and AT1 receptor
density in aldosterone-treated rats were not
statistically different from those of vehicle-treated rats. However,
immunohistochemical studies showed that the highest adrenal
AT1 receptor expression was shifted from the zona
glomerulosa to the zona fasciculata after aldosterone
treatment. In contrast, adrenal AT2 mRNA and
AT2 receptor density in aldosterone-treated
rats were decreased by approximately 50% and 40%, respectively,
compared with vehicle-treated rats (P<0.05).
Aldosterone-induced decrease in adrenal AT2
receptor expression occurred mainly in the medulla. Thus,
aldosterone differentially modulates the expression of
AT1 and AT2 receptors in the adrenal gland.
Although the function of the AT2 receptor in the adrenal
gland is largely unknown, our data indicate that
aldosterone may modulate the effect of Ang II by altering
the location of AT1 receptors and by reducing the number of
AT2 receptors in the adrenal gland.
© 1998 American Heart Association, Inc.
Scientific Contributions
Differential Regulation of Angiotensin II Receptor Subtypes in the Adrenal Gland
Role of Aldosterone
Key Words: aldosterone receptors, angiotensin II adrenal gland Northern blot radioligand assay immunohistochemistry
This article has been cited by other articles:
![]() |
F. Xiao, J. R. Puddefoot, S. Barker, and G. P. Vinson Mechanism for Aldosterone Potentiation of Angiotensin II-Stimulated Rat Arterial Smooth Muscle Cell Proliferation Hypertension, September 1, 2004; 44(3): 340 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Moore, N. T. Heiderstadt, E. Huang, N. L. Howell, Z.-Q. Wang, H. M. Siragy, and R. M. Carey Selective Inhibition of the Renal Angiotensin Type 2 Receptor Increases Blood Pressure in Conscious Rats Hypertension, May 1, 2001; 37(5): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gallinat, S. Busche, M. K. Raizada, and C. Sumners The angiotensin II type 2 receptor: an enigma with multiple variations Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E357 - E374. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Wang, L. J. Millatt, N. T. Heiderstadt, H. M. Siragy, R. A. Johns, and R. M. Carey Differential Regulation of Renal Angiotensin Subtype AT1A and AT2 Receptor Protein in Rats With Angiotensin-Dependent Hypertension Hypertension, January 1, 1999; 33(1): 96 - 101. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |